EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Rethinking interleukin-31: A neuroimmune orchestrator of itch beyond Th2 immunity

Hiroyuki Irie, Kenji Kabashima

Allergology International · 2026-07 · 75 (3) · 358-365

DOI: 10.1016/j.alit.2026.04.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Allergology International, 2026-07. Verfasst von Hiroyuki Irie und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan. Electronic address: hirie@kuhp.kyoto-u.ac.jp. Hauptthemen laut MEDLINE: Pruritus, Interleukins, Th2 Cells, Neuroimmunomodulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin (IL)-31 has emerged as a pivotal mediator of pruritus. Since its initial identification, substantial progress has been made in elucidating the role of IL-31 in itch pathophysiology, particularly its direct effects on peripheral sensory neurons. Elevated IL-31 expression has been documented in a wide range of pruritic skin diseases, including atopic dermatitis, prurigo nodularis, and systemic disorders. Beyond its pruritogenic activity, IL-31 is increasingly recognized as a neuroimmune cytokine that links immune-cell activation to sensory-neuronal circuits and, in some contexts, may also exert immunomodulatory effects. IL-31 signals through a heterodimeric receptor complex composed of IL-31 receptor α and oncostatin M receptor β, activating downstream pathways. In sensory neurons, IL-31 receptor signaling defines a distinct pruritic pathway, but emerging human transcriptomic data indicate that IL-31-responsive neurons are more heterogeneous than the canonical murine NP3 subset, highlighting an important translational consideration. In this review, we summarize current knowledge regarding IL-31 biology, including its cellular sources, receptor expression, and signaling mechanisms, and discuss its role in both pruritic and non-pruritic diseases. We further evaluate therapeutic strategies targeting the IL-31/IL-31 receptor axis and consider the emerging concept that IL-31 blockade may relieve itch while simultaneously disinhibiting dendritic cell-driven type 2 inflammatory programs in selected contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PruritusInterleukinsTh2 CellsNeuroimmunomodulationHumansAnimalsSignal TransductionReceptors, Interleukin

Stichwörter der Autor:innen

Atopic dermatitisCytokineIL-31PruritusTh2

Substanzen

InterleukinsIL31 protein, humanReceptors, Interleukin

Autor:innen und Institutionen

  • Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan. Electronic address: hirie@kuhp.kyoto-u.ac.jp.
  • Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; A∗STAR Skin Research Labs (A∗SRL), Singapore Immunology Network (SIgN), and Skin Research Institute of Singapore (SRIS), Agency for…

Zitieren

APA

Irie, H., & Kabashima, K. (2026). Rethinking interleukin-31: A neuroimmune orchestrator of itch beyond Th2 immunity. Allergology International, 75(3), 358-365. https://doi.org/10.1016/j.alit.2026.04.004

Vancouver

Irie H, Kabashima K. Rethinking interleukin-31: A neuroimmune orchestrator of itch beyond Th2 immunity. Allergology International. 2026;75(3):358-365. doi:10.1016/j.alit.2026.04.004

BibTeX
@article{Irie2026,
  author = {Irie, Hiroyuki and Kabashima, Kenji},
  title = {Rethinking interleukin-31: A neuroimmune orchestrator of itch beyond Th2 immunity},
  journal = {Allergology International},
  year = {2026},
  volume = {75},
  number = {3},
  pages = {358--365},
  doi = {10.1016/j.alit.2026.04.004}
}
Kostenlos starten →